News | March 19, 2012

National Physical Laboratory Purchases Nucletron's Brachytherapy Afterloader

March 19, 2012 -- The National Physical Laboratory (NPL), the United Kingdom's national measurement institute, recently purchased a Flexitron afterloader from Nucletron, an Elekta company. NPL will continue to offer its brachytherapy calibration service with the new afterloader and ensure source calibrations in radiotherapy centers remain traceable to NPL's primary standard.

"We chose Flexitron because it is a highly advanced brachytherapy platform that met all our requirements, offering the accuracy necessary to achieve the scientific excellence we strive for," says Thorsten Sander, senior research scientist at NPL. "Flexitron also provides us the opportunity to collaborate in the development of new technologies, to expand brachytherapy products and applications."

Nucletron and NPL have collaborated since 1992.

Flexitron is an advanced afterloader that takes brachytherapy to a new level. With robust safety features and flexible 40-channel configuration, Flexitron is designed to treat both very small and very large tumors without reconnections in intuitive 1 mm steps.

Accurate determination of source positions is simplified and reliability is enhanced with Nucletron's zero reference source positioning system, which defines dwell positions in absolute values. This significantly reduces the chance of human error; no additional measures or manual recalculations are required. Procedures take less time and are easier to check. Flexitron patented source drives are more precise and
durable than ever, providing reliable treatment from year to year.

For more information: www.nucletron.com, www.npl.co.uk/ionising-radiation

Related Content

New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with...
Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Prostate Brachytherapy Shows Low Incidence of Short-Term Complications
News | Brachytherapy Systems | October 31, 2018
A new analysis of nearly 600 men receiving brachytherapy for prostate cancer shows overall procedure-related...
News | Brachytherapy Systems, Women's Healthcare | October 25, 2018
iCAD Inc. announced new clinical research demonstrating positive outcomes supporting the use of the Xoft Axxent...